Infection by multidrug-resistant Chryseobacterium indologenes in cases of obstructive uropathy: Case series with short review

Palewar, Meghna; Mudshingkar, Swati; Dohe, Vaishali; Bharadwaj, Renu

doi:10.4103/mjdrdypu.mjdrdypu_201_16

Cited by 6 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One of the isolates from catheterised urine sample was multi-drug resistant and it was correlated with the study done by Palewar MS, Mudshingkar SS et al in 2016. 10 The resistance to multiple antibiotics by C.indologenes was observed and confirmed in this study. As a conclusion, C. indologenes should be recognized as an emerging nosocomial pathogen.…”

Section: Discussionsupporting

confidence: 80%

Increased recognition of Chryseobacterium species as an emerging cause of nosocomial infection at a tertiary care centre in Mangalore

John¹,

Sharma²,

Nayak³

et al. 2018

JIMD

View full text Add to dashboard Cite

Background: Chryseobacterium is an environmental inhabitant which is periodically discovered in human specimens. It is one of the prominent pathogens among non-fermentative Gram-negative bacilli. The members of Chryseobacterium genus are mainly noted for their multi-drug resistance. Materials and Methods: Patients admitted in tertiary care centre were examined for 6 months. Chryseobacterium species were isolated from different clinical samples using conventional methods (according to CLSI guidelines) and antibiotic susceptibility patterns were obtained. This study also comprised of associated underlying risk factors, comorbidities and eventually the treatment outcome. Results: A total of 9 isolates of C. indologenes were recovered from specific samples like urine, sputum, pus and ascitic fluid. Among which, four patients had respiratory tract infection, one had chronic liver disease, two had wound infection and in other two, the organism was isolated from the sample of catheterized urine. The two patients were in the intensive care unit and had central lines and indwelling catheter. The common underlying risk factors identified were diabetes, hypertension and coronary artery disease. Conclusion: This case concludes that C. indologenes may cause symptomatic disease in immunocompetent persons with otherwise no associated underlying risk factors.

show abstract

Section: Discussionsupporting

confidence: 80%

Increased recognition of Chryseobacterium species as an emerging cause of nosocomial infection at a tertiary care centre in Mangalore

John¹,

Sharma²,

Nayak³

et al. 2018

JIMD

View full text Add to dashboard Cite

show abstract

“…C. indologenes was first reported in 1993 by Bhagawati et al in a patient presenting with ventilator-associated pneumonia [10]. Later, more cases presenting as bacteremia, pneumonia, meningitis, pyomyositis, keratitis, and also contaminated surgically implanted devices have been reported [1,6,8,11]. Appropriate choice of antimicrobial agents is challenging due to the unpredictability and multiple drug resistance of this microorganism to antibiotics [3].…”

Section: Introductionmentioning

confidence: 99%

Chryseobacterium indologenes, an Emerging Bacteria: A Case Report and Review of Literature

Izaguirre-Anariba¹,

Sivapalan²

2020

Cureus

View full text Add to dashboard Cite

Chryseobacterium indologenes are aerobic, Gram negative, nonfermentative rods that are intrinsically multi-drug resistant. Reported infections include bacteremia, pneumonia, meningitis, myositis, keratitis, and indwelling devices. We present the clinical course of a 52year-old African male with a medical history of end stage renal disease (ESRD) in hemodialysis with multiple episodes of central line-associated bloodstream infections (CLABSI) presenting with symptoms of chills, malaise, and localized erythema on insertion site of permacath. Blood cultures obtained from catheter showed C. indologenes. Successful response was obtained with piperacillin/tazobactam based on sensitivity and removal of indwelling catheter. Given the increase in the number of cases reported in the literature, guidelines for the management of this pathogen should be considered.

show abstract

“…The choice of antibiotic in infections by C. indologenes is difficult, as it is usually resistant to aminoglycosides, erythromycin, penicillins, aztreonam, cephalosporins of first and second generation, ceftriaxone, chloramphenicol and variable resistance to imipenem and meropenem. The most active antimicrobials demonstrated in a large multicenter study were the fluoroquinolones (garenoxacin, gatifloxacin and levofloxacin), piperacillin-tazobactam, cefepime, ceftazidime, rifampicin and trimethoprimsulfamethoxazole[1,2,8,11,12], although in our case it responded to cefotaxime. Bacteremia due to C. indologenes is rare in children, but we consider it is important to know this germ because of the serious infections it can cause and the multiresistance to antibiotics that it presents.…”

mentioning

confidence: 50%

Chryseobacterium indologenes bacteremia in a healthy 2-month-old baby

Mora

Dyląg²,

Jiménez

et al. 2020

Reviews in Medical Microbiology

View full text Add to dashboard Cite

Chryseobacterium indologenes is a Gram-negative bacteria rarely pathogenic in humans that can produce serious infections, especially, in children with comorbidities. Only a few cases of bacteremia have been published by C. indologenes, the majority in Taiwan. We show a Spanish healthy 2-month-old baby, who was diagnosed with this germ at our hospital, to report on the serious infections that it can cause and the multiple drug resistance to antibiotics that it shows.

show abstract

Infection by multidrug-resistant Chryseobacterium indologenes in cases of obstructive uropathy: Case series with short review

Cited by 6 publications

References 0 publications

Increased recognition of Chryseobacterium species as an emerging cause of nosocomial infection at a tertiary care centre in Mangalore

Increased recognition of Chryseobacterium species as an emerging cause of nosocomial infection at a tertiary care centre in Mangalore

Chryseobacterium indologenes, an Emerging Bacteria: A Case Report and Review of Literature

Chryseobacterium indologenes bacteremia in a healthy 2-month-old baby

Contact Info

Product

Resources

About